iotaMotion, Inc., an Iowa City, Iowa-based leader in developing advanced robotic-assisted systems for cochlear implant surgery, raised $12m in Series A funding.
The round was led by Research Corporation Technologies, Inc. (RCT) with participation from Mutual Capital Partners, ISA Ventures, and Next Level Ventures. Christopher Martin, President of RCT, and Wayne Wallace, Co-Founder and Managing Partner of Mutual Capital Partners, will join iotaMotion’s Board of Directors.
The company intends to use the funds to accelerate commercial expansion of the iotaSOFT® Insertion System.
Led by Mike Lobinsky, CEO, iotaMotion is developing surgical robotic assistive technologies with the goal of advancing cochlear implant surgery beyond human capability. The company’s solutions aim to standardize cochlear implant electrode array insertion, and to provide control in surgical care settings with the goal of expanding access to cochlear implant interventions for both surgeons and patients.
iotaMotion is also expanding its Scientific Advisory Board, with the addition of Bruce Gantz, MD, neurotologist and distinguished professor at the University of Iowa, Professor Thomas Lenarz, MD, PhD, Chairman of the Department of Otolaryngology, Hannover Medical School, and Camille Dunn, PhD, research audiologist and Director of the University of Iowa Cochlear Implant Clinical Research Center. The addition of these advisors will ensure iotaMotion continues to deliver innovative products that will push the field of cochlear implants forward.
FinSMEs
26/07/2023